PATHOLOGY AND TOXICOLOGY OF REPEATED DOSES OF HYDRAZINE AND 1,1-DIMETHYLHYDRAZINE IN MONKEYS AND RATS
Technical documentary rept. Mar 1962-Dec 1963
AIR FORCE AEROSPACE MEDICAL RESEARCH LAB WRIGHT-PATTERSON AFB OH
Pagination or Media Count:
Twelve rhesus monkeys received daily doses of hydrazine ranging from 5 to 20 mgkg and totaling from 4 to 20 injections. Seven monkeys received 20 injections of 1, 1-dimethylhydrazine at 10 mgkg. All animals lost weight during the experiment. In the hydrazine-treated group of monkeys, serum glutamic oxaloacetic transaminase and bilirubin rose with doses of 20 mgkg, with more than a twentyfold increase of SGOT in two animals. Most of those receiving 20 mgkg exhibited loss of appetite, vomiting, lethargy, and severe weakness. Microscopic examination revealed lipid accumulation in the liver, myocardium, kidney, and skeletal muscle. Massive liver necrosis was observed in one animal. In those monkeys receiving UDMH, blood glucose rose significantly toward the end of the experiment. Some lipid was deposited in the heart, liver, and kidney, but to a much lesser degree than was observed with hydrazine, and it could only be demonstrated with special fat stain. Rats given from 3 to 23 doses of 10 or 20 mgkgday hydrazine did not show marked fatty changes as observed in the monkeys.
- Liquid Propellant Rocket Engines